Target intelligence / Profile preview

Heat shock factor 1 (HSF1) (HSF1)

Target
HSF1
Molecular classification
Transcription factor
01

Overview

Heat shock factor 1 (HSF1) is the master transcription factor responsible for the biological process known as the heat shock response or "heat induction" of molecular chaperones (PMID: 2150530). Under basal conditions, HSF1 is primarily sequestered in an inactive monomeric state by chaperones such as HSP90 and HSP70. Upon exposure to thermal or proteotoxic stress, HSF1 is released, undergoes homotrimerization, and translocates to the nucleus where it binds to heat shock elements (HSEs) in the promoters of target genes. This activation leads to the rapid transcription of heat shock proteins (HSPs), which act as chaperones to maintain protein homeostasis and prevent apoptosis under stressful conditions (PMID: 22441905). In the context of human disease, HSF1 is a major therapeutic target in oncology because cancer cells frequently overexpress HSF1 to survive the metabolic and proteotoxic stressors of the tumor microenvironment (PMC2670238). Conversely, HSF1 activation is being explored as a strategy for treating neurodegenerative diseases, where the heat induction of chaperones can facilitate the clearance of toxic protein aggregates. Small molecule inhibitors, such as triptolide and quercetin, have been shown to interfere with HSF1-mediated transcriptional activity, effectively blocking the heat induction of cytoprotective proteins like HSP70 (PMC2670238). Recent drug development efforts focus on direct HSF1 inhibitors to overcome the specific proteotoxic dependencies of aggressive tumors.

Other names
Heat shock transcription factor 1HSTF1HSF 1
02

Mechanism of action

Inhibition of HSF1 trimerization, DNA binding, or phosphorylation to prevent the induction of heat shock proteins and sensitize cells to proteotoxic stress.

03

Biological functions

Regulation of transcriptionResponse to heat shockProtein foldingSignal transductionApoptosisCell survival
04

Disease associations

CancerNeurodegenerative diseaseInflammation
05

Safety considerations

Disruption of basal proteostasis in healthy cellsPotential for systemic toxicity in high-protein-turnover tissuesImpairment of physiological cytoprotective responsesInhibition of thermotolerance
06

Interacting drugs

Triptolide

5 more in the full profile.

07

Biomarkers

HSP70 expression levelsHSP27 expression levelsHSF1 phosphorylation status (Ser230)HSF1 DNA-binding activity

Beyond the preview

Go deeper on Heat shock factor 1 (HSF1) (HSF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock factor 1 (HSF1) (HSF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call